Literature DB >> 10644757

Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state.

W G Thomas1, H Qian, C S Chang, S Karnik.   

Abstract

G protein-coupled receptors are thought to isomerize between distinct inactive and active conformations, an idea supported by receptor mutations that induce constitutive (agonist-independent) activation. The agonist-promoted active state initiates signaling and, presumably, is then phosphorylated and internalized to terminate the signal. In this study, we examined the phosphorylation and internalization of wild type and constitutively active mutants (N111A and N111G) of the type 1 (AT(1A)) angiotensin II receptor. Cells expressing these receptors were stimulated with angiotensin II (AngII) and [Sar(1),Ile(4),Ile(8)]AngII, an analog that only activates signaling through the constitutive receptors. Wild type AT(1A) receptors displayed a basal level of phosphorylation, which was stimulated by AngII. Unexpectedly, the constitutively active AT(1A) receptors did not exhibit an increase in basal phosphorylation nor was phosphorylation enhanced by AngII stimulation. Phosphorylation of the constitutively active receptors was unaffected by pretreatment with the non-peptide AT(1) receptor inverse agonist, EXP3174, and was not stimulated by the selective ligand, [Sar(1),Ile(4),Ile(8)]AngII. Paradoxically, [Sar(1),Ile(4), Ile(8)]AngII produced a robust ( approximately 85% of AngII), dose-dependent phosphorylation of the wild type AT(1A) receptor at sites in the carboxyl terminus similar to those phosphorylated by AngII. Moreover, internalization of both wild type and constitutive receptors was induced by AngII, but not [Sar(1),Ile(4),Ile(8)]AngII, providing a differentiation between the phosphorylated and internalized states. These data suggest that the AT(1A) receptor can attain a conformation for phosphorylation without going through the conformation required for inositol phosphate signaling and provide evidence for a transition of the receptor through multiple states, each associated with separate stages of receptor activation and regulation. Separate transition states may be a common paradigm for G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644757     DOI: 10.1074/jbc.275.4.2893

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

2.  Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7.

Authors:  C Ullmer; S Zoffmann; B Bohrmann; H Matile; L Lindemann; Pj Flor; P Malherbe
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

3.  Binding characteristics of [3H]-JSM10292: a new cell membrane-permeant non-peptide bradykinin B2 receptor antagonist.

Authors:  A Faussner; S Schüssler; J Feierler; M Bermudez; J Pfeifer; K Schnatbaum; T Tradler; M Jochum; G Wolber; C Gibson
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

5.  Comparison of class A and D G protein-coupled receptors: common features in structure and activation.

Authors:  Markus Eilers; Viktor Hornak; Steven O Smith; James B Konopka
Journal:  Biochemistry       Date:  2005-06-28       Impact factor: 3.162

6.  Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.

Authors:  Lucien Gazi; Sarah A Nickolls; Philip G Strange
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  Selective knockdown of AT1 receptors by RNA interference inhibits Val5-ANG II endocytosis and NHE-3 expression in immortalized rabbit proximal tubule cells.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Am J Physiol Cell Physiol       Date:  2007-04-11       Impact factor: 4.249

8.  Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors.

Authors:  Arun K Shukla; Jonathan D Violin; Erin J Whalen; Diane Gesty-Palmer; Sudha K Shenoy; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-11       Impact factor: 11.205

9.  Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.

Authors:  Jérôme Cabana; Brian Holleran; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

10.  Genetic deletion of p90 ribosomal S6 kinase 2 alters patterns of 5-hydroxytryptamine 2A serotonin receptor functional selectivity.

Authors:  Ryan T Strachan; Noah Sciaky; Mark R Cronan; Wesley K Kroeze; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2009-11-20       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.